Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Archemix Corp.

Home Clinical Trial Sponsors and OrganizationsArchemix Corp.

Archemix Corp.

ACTIVE

加利福尼亚州旧金山县, California, United Stateswww.archemix.comPrivate51–100 employeesEstablished: 2000-01-01

Part of Baxter International, Inc.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

13

7 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2000

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 2

5

38.5%

Phase 1

1

7.7%

Trial Status Distribution

Active, not recruiting

7

53.9%

Completed

2

15.4%

Terminated

3

23.1%

Withdrawn

1

7.7%

Clinical Trials

Trials sponsored by this organization (13)

Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy

Feb 2009100 participants

A Randomized, Double-blind, Placebocontrolled, Clinical Outcome Study of ARC1779 Injection in Patients with Thrombotic Microangiopathy - ND

Active, not recruiting

Jan 2009100 participants

Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy

Dec 2008100 participants

A Randomized, Double-blind, Placebo-controlled, Clinical Outcome study of ARC1779 Injection in Patients with Thrombotic Microangiopathy - Study of ARC1779 Injection in Patients with Thrombotic Microangiopathy

Active, not recruiting

Oct 2008100 participants

A Study of the Effect of ARC1779 Injection on Cerebral Microembolism in PatientsUndergoing Carotid Endarterectomy

Active, not recruiting

Oct 2008100 participants

A Randomized, Double-blind, Placebo-controlled, Clinical Outcome Study of ARC1779 Injection in Patients with Thrombotic Microangiopathy. - Study of ARC1779 Injection in Patients with Thrombotic Microangiopathy

Active, not recruiting

Oct 2008100 participants

A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B

Oct 20082 participants

ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders

Jan 200828 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials13
Approvals
News

Back to Organizations